Biomarker levels were compared between survivors vs non-survivors (Fig. 4A–C), where significantly higher levels of NSE in HD non-survivors (5.7 ng/ml) were observed compared to those who survived (5.2 ng/ml) (Fig. 4B). The gene discussed is ENO2; the disease is Huntington disease.